Table 1A.
Sample characteristics of participants who provided data on brain glucose concentrations and ratios of glycolytic amino acids:glucose
| Whole sample | CN | AYSMAD | AD | P-value | |
|---|---|---|---|---|---|
| N | 43 | 14 | 15 | 14 | |
| Sex (f/m) | 16/27 | 4/10 | 5/10 | 7/7 | 0.53 |
| Age death | 86.6 (9.5) 62.9 – 99.2 |
82.6 (11.0) 64.2 – 99.2 |
89.2 (7.9) 71.9 – 96.4 |
87.9 (8.9) 62.9 – 98.7 |
0.15 |
| PMI (Hours) | 15.3 (6.8) 2.0–33.0 |
16.9 (6.4) 7.0–28.0 |
14.8 (8.1) 2.0–33.0 |
14.7 (6.0) 3.0–23.0 |
0.70 |
| APOE (ε4−/ε4+) | 33/10 | 12/2 | 11/4 | 10/4 | 0.73 |
AD = Alzheimer’s disease; CN = control; ASYMAD = asymptomatic Alzheimer’s disease Sex, and APOE genotype variables were compared using Fisher’s exact test, age of death and PMI were compared using the Kruskal-Wallis Test